Biotech Biz Zymergen Lands $400M Series C Funding
Molecular manufacturing technology company Zymergen said on Thursday that it has raised over $400 million in its latest round of funding that it will use to accelerate product development and commercialization....To view the full article, register now.
Already a subscriber? Click here to view full article